|Follow up complete
|Study Start Date:
|Study Made Public:
A randomized, placebo-controlled, partially blinded Phase 1b clinical trial to evaluate the safety and immunogenicity of BCG revaccination, H4:IC31, and H56:IC31 in healthy, HIV-1 uninfected adolescent participants
HVTN 602 (AERAS A-042) is a Phase Ib clinical trial to evaluate the safety and immunogenicity of vaccine regimens using of BCG revaccination, H4:IC31, and H56:IC31.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.